AAM taps John Murphy as president and CEO Murphy most recently served as the chief policy officer at the Biotechnology Innovation Organization. AAM to Congress: Pass key bills considered by the Senate HELP Committee AAM commended the slated mark up by the Senate Health, Education, Labor and Pensions Committee of two pieces of legislation. Kroger announces extension of exchange offers, consent solicitations for Albertsons Co.’s notes Kroger has extended the expiration date of the previously announced offers to exchange any and all outstanding notes of Albertsons Co.'s and its umbrella stores. AAM: Generic medicines increase patient access more than government negotiated price controls AAM is urging Congress and regulators to stop patent abuses and streamline approvals. Sandoz report weighs in on how to solve America’s drug shortage problem For the last six years, 84% of the medicines in shortage have been generics. Biosimilars Council urges House to pass patent thicket legislation S. 150 passed the Senate and was placed on the House of Representatives' suspension calendar. AAM, Biosimilars Council releases statement on statement on Senate Judiciary Markup of PREVAIL and PERA The Association for Accessible Medicines and its Biosimilars Council oppose passage of the PREVAIL Act and the PERA Act. The Giant Company to sell ready-to-drink cocktails in Pennsylvania The company’s decision comes after the signing of Act 86 in the state earlier this year. Former FDA commissioner Scott Gottlieb will keynote AAM's annual meeting Scott Gottlieb also will moderate the CEOs Unplugged session, where healthcare executives will share their candid insights and industry perspectives. Baltimore settles with Teva, Walgreens prior to scheduled opioid trial This is the latest in a series of settlements totaling $402.5 million, per a Reuters report. First Previous 5 6 7 8 9 Next Last
